InvestorsHub Logo
Followers 21
Posts 1234
Boards Moderated 0
Alias Born 12/10/2010

Re: bbking2003 post# 6291

Saturday, 03/15/2014 6:16:55 PM

Saturday, March 15, 2014 6:16:55 PM

Post# of 699694
Separately, DCVax-L was also cleared as eligible for reimbursement through German sickness funds (i.e., insurance companies), which prompted six hospitals to apply for reimbursement eligibility. This represents a solid first step in validating DCVax-L and should help generate revenue to offset some of its ongoing losses, but its phase 3 study of DCVax-L in the U.S. for glioblastoma multiforme, the most lethal form of brain cancer, should remain the focus of shareholders in the meantime.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News